6 terminated. 6 Phase 2, 4 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 6 | Terminated 6 |
| Phase 1 | 4 | Terminated 4 |
Follow Brain Tumor: new trials by email Literature Review of Brain Tumor trials Research Report on Brain Tumor
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Seizure Prophylaxis in Patients With Glioma or Brain Metastasis Lacosamide, Levetiracetam - Glioma, Glioma of Brain | Phase 2 | Terminated | Duke University | 4 | 2019-01-31 | 2023-04-13 |
| [18F]Fluciclovine and [18F]FLT PET/CT Assessment of Primary High-Grade Brain Tumors [18F]FLT, [18F]Fluciclovine - Brain Tumor | Phase 1 / Phase 2 | Terminated | University of Utah | 10 | 2018-09-24 | 2024-12-27 |
| Zotiraciclib (TG02) Plus Dose-Dense or Metronomic Temozolomide Followed by Randomized Phase II Trial of Zotiraciclib (TG02) Plus Temozolomide Versus Temozolomide Alone in Adults With Recurrent Anaplastic Astrocytoma and Glioblastoma Zotiraciclib (TG02), Temozolomide (TMZ) - Brain Tumor, Astrocytoma | Phase 1 / Phase 2 | Terminated | National Cancer Institute (NCI) | 53 | 2016-12-14 | 2026-02-23 |
| Tolerability Study of Xerecept® in Pediatric Patients XERECEPT - Brain Edema, Brain Tumor | Phase 1 / Phase 2 | Terminated | Celtic Pharma Development Services | 15 | 2010-06-01 | 2013-07-30 |
| A Study of Intraventricular Liposomal Encapsulated Ara-C (DepoCyt) in Patients With Recurrent Glioblastoma ITV DepoCyt + Temozolomide - Glioblastoma Multiforme, Glioma | Phase 1 / Phase 2 | Terminated | Medical University of South Carolina | 12 | 2009-09-01 | 2019-02-12 |
| Ritonavir and Lopinavir in Treating Patients With Progressive or Recurrent High-Grade Glioma ritonavir, lopinavir - Brain Tumor, Anaplastic Astrocytoma | Phase 2 | Terminated | Case Comprehensive Cancer Center | 19 | 2009-01-01 | 2013-06-10 |
Brain Neoplasms (6) · Astrocytoma (3) · Glioblastoma (3) · Glioma (3) · Gliosarcoma (2) · Brain Edema (1) · Edema (1) · Ependymoma (1) · Oligodendroglioma (1) · Recurrence (1)
Brain Diseases (6) · Central Nervous System Diseases (6) · Central Nervous System Neoplasms (6) · Neoplasms (6) · Neoplasms by Site (6) · Nervous System Diseases (6) · Nervous System Neoplasms (6) · Neoplasms by Histologic Type (4) · Neoplasms, Germ Cell and Embryonal (4) · Neoplasms, Glandular and Epithelial (4) · Neoplasms, Nerve Tissue (4) · Neoplasms, Neuroepithelial (4) · Neuroectodermal Tumors (4) · Pathological Conditions, Signs and Symptoms (2) · Disease Attributes (1)
Temozolomide (2) · 14-methyl-20-oxa-5,7,14,26-tetraazatetracyclo(19.3.1.1(2,6).1(8,12))heptacosa-1(25),2(26),3,5,8(27),9,11,16,21,23-decaene (1) · Corticotropin-Releasing Hormone (1) · Lacosamide (1) · Levetiracetam (1) · Lopinavir (1) · Ritonavir (1) · alovudine (1) · fluciclovine F-18 (1)
Case Comprehensive Cancer Center (1) · Celtic Pharma Development Services (1) · Duke University (1) · Medical University of South Carolina (1) · National Cancer Institute (NCI) (1) · University of Utah (1)
United States (6)
Annick Desjardins, M.D. (1) · Bruce M Frankel, MD (1) · David Peereboom, MD (1) · Gustavo Leone (1) · Jeffrey Yap, PhD (1) · Jing Wu, M.D. (1) · Stewart Goldman, MD (1)